• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由芳基胍合成 2-芳基氨基取代的 5,6-二氢吡啶并[2,3-d]嘧啶-7(8H)-酮。

Synthesis of 2-arylamino substituted 5,6-dihydropyrido[2,3-d]pyrimidine-7(8H)-ones from arylguanidines.

机构信息

Grup d'Enginyeria Molecular, Institut Químic de Sarrià, Universitat Ramon Llull, Via Augusta 390, 08017 Barcelona, Spain.

出版信息

Mol Divers. 2012 Nov;16(4):639-49. doi: 10.1007/s11030-012-9398-6. Epub 2012 Oct 10.

DOI:10.1007/s11030-012-9398-6
PMID:23054532
Abstract

A practical protocol was developed for the synthesis of 2-arylamino substituted 4-amino-5,6-dihydropyrido[2,3-d]pyrimidin-7(8H)-ones from α,β-unsaturated esters, malononitrile, and an aryl substituted guanidine via the corresponding 3-aryl-3,4,5,6- tetrahydropyrido[2,3-d]pyrimidin-7(8H)-ones. Such compounds are formed upon treatment of 2-methoxy-6-oxo-1,4,5,6-tetrahydropyridine-3-carbonitriles with an aryl substituted guanidine in 1,4-dioxane and are converted to the desired 4-aminopyridopyrimidines with NaOMe/MeOH through a Dimroth rearrangement. The overall yields of this three-step protocol are, generally speaking, higher than the multicomponent reaction, previously developed by our group, between an α,β-unsaturated ester, malononitrile, and an aryl substituted guanidine.

摘要

开发了一种实用的方案,用于通过α,β-不饱和酯、丙二腈和芳基取代胍,从相应的 3-芳基-3,4,5,6-四氢吡啶并[2,3-d]嘧啶-7(8H)-酮合成2-芳胺取代的 4-氨基-5,6-二氢吡啶并[2,3-d]嘧啶-7(8H)-酮。这些化合物是通过将 2-甲氧基-6-氧代-1,4,5,6-四氢吡啶-3-甲腈与芳基取代胍在 1,4-二氧六环中处理而形成的,并通过 Dimroth 重排,用 NaOMe/MeOH 将其转化为所需的 4-氨基吡啶并嘧啶。总体而言,三步方案的总收率高于我们小组之前开发的α,β-不饱和酯、丙二腈和芳基取代胍之间的多组分反应。

相似文献

1
Synthesis of 2-arylamino substituted 5,6-dihydropyrido[2,3-d]pyrimidine-7(8H)-ones from arylguanidines.由芳基胍合成 2-芳基氨基取代的 5,6-二氢吡啶并[2,3-d]嘧啶-7(8H)-酮。
Mol Divers. 2012 Nov;16(4):639-49. doi: 10.1007/s11030-012-9398-6. Epub 2012 Oct 10.
2
A new and practical method for the synthesis of 6-aryl-5,6-dihydropyrido[2,3-d]pyrimidine-4,7(₃Η,8Η)-diones.一种新型实用的 6-芳基-5,6-二氢哒嗪并[2,3-d]嘧啶-4,7(3H,8H)-二酮的合成方法。
Mol Divers. 2013 Aug;17(3):525-36. doi: 10.1007/s11030-013-9450-1. Epub 2013 May 26.
3
Solid-phase synthesis of 2-substituted 4-amino-7-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidines: an example of cyclization-assisted cleavage.
Mol Divers. 2003;6(1):3-11. doi: 10.1023/a:1024830721010.
4
Pyrido[2,3-]pyrimidin-7(8)-ones: Synthesis and Biomedical Applications.吡啶并[2,3-]嘧啶-7(8)-酮:合成与生物医学应用。
Molecules. 2019 Nov 16;24(22):4161. doi: 10.3390/molecules24224161.
5
Solid-phase synthesis of 2-substituted 4-amino-7-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidines.
Mol Divers. 2003;6(2):85-92. doi: 10.1023/b:modi.0000006835.60273.b3.
6
A diversity oriented, microwave assisted synthesis of N-substituted 2-hydro-4-amino-pyrido[2,3-d]pyrimidin-7(8H)-ones.一种面向多样性的、微波辅助合成N-取代的2-氢-4-氨基吡啶并[2,3-d]嘧啶-7(8H)-酮的方法。
Mol Divers. 2009 Feb;13(1):39-45. doi: 10.1007/s11030-008-9096-6. Epub 2008 Nov 27.
7
An unusual Michael addition of 3,3-dimethoxypropanenitrile to 2-aryl acrylates: a convenient route to 4-unsubstituted 5,6-dihydropyrido[2,3-d]pyrimidines.3,3-二甲氧基丙腈与 2-芳基丙烯酸酯的非常规迈克尔加成反应:合成 4-未取代的 5,6-二氢吡啶并[2,3-d]嘧啶的便捷途径。
J Org Chem. 2010 Jan 15;75(2):487-90. doi: 10.1021/jo902345r.
8
Synthesis of highly substituted 2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-ones from 4,6-dichloro-5-formylpyrimidine, amines and aldehydes.从 4,6-二氯-5-甲酰基嘧啶、胺和醛合成高取代的 2,3-二氢嘧啶并[4,5-d]嘧啶-4(1H)-酮。
Mol Divers. 2011 Nov;15(4):839-47. doi: 10.1007/s11030-011-9314-5. Epub 2011 Apr 21.
9
Simple approach to thieno[3,2-d]pyrimidines as new scaffolds of antimicrobial activities.以噻吩并[3,2-d]嘧啶作为新型抗菌活性支架的简单方法。
Acta Pharm. 2016 Sep 1;66(3):331-51. doi: 10.1515/acph-2016-0029.
10
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.作为镇痛和抗炎剂的4-取代吡啶并[2,3-d]嘧啶-4(1H)-酮的合成
Bioorg Med Chem Lett. 2009 Jul 1;19(13):3392-7. doi: 10.1016/j.bmcl.2009.05.044. Epub 2009 May 18.

引用本文的文献

1
The Use of a Penta-Deuterophenyl Substituent to Improve the Metabolic Stability of a Tyrosine Kinase Inhibitor.使用五氘代苯基取代基提高酪氨酸激酶抑制剂的代谢稳定性
Molecules. 2024 Dec 22;29(24):6042. doi: 10.3390/molecules29246042.
2
Developments of pyridodipyrimidine heterocycles and their biological activities.嘧啶并嘧啶杂环的发展及其生物活性。
Mol Divers. 2024 Apr;28(2):927-964. doi: 10.1007/s11030-023-10623-9. Epub 2023 Feb 25.
3
The Dimroth Rearrangement in the Synthesis of Condensed Pyrimidines - Structural Analogs of Antiviral Compounds.

本文引用的文献

1
An unusual Michael addition of 3,3-dimethoxypropanenitrile to 2-aryl acrylates: a convenient route to 4-unsubstituted 5,6-dihydropyrido[2,3-d]pyrimidines.3,3-二甲氧基丙腈与 2-芳基丙烯酸酯的非常规迈克尔加成反应:合成 4-未取代的 5,6-二氢吡啶并[2,3-d]嘧啶的便捷途径。
J Org Chem. 2010 Jan 15;75(2):487-90. doi: 10.1021/jo902345r.
2
Novel heterocycle-substituted pyrimidines as inhibitors of NF-kappaB transcription regulation related to TNF-alpha cytokine release.
Bioorg Med Chem Lett. 2008 Jan 15;18(2):653-6. doi: 10.1016/j.bmcl.2007.11.064. Epub 2007 Nov 22.
3
2-Methoxy-6-oxo-1,4,5,6-tetrahydropyridine-3-carbonitriles: versatile starting materials for the synthesis of libraries with diverse heterocyclic scaffolds.
J Comb Chem. 2005 May-Jun;7(3):436-48. doi: 10.1021/cc049828y.
稠合嘧啶(抗病毒化合物的结构类似物)合成中的迪莫思重排反应
Chem Heterocycl Compd (N Y). 2021;57(4):342-368. doi: 10.1007/s10593-021-02913-7. Epub 2021 May 15.
4
Pyrido[2,3-]pyrimidin-7(8)-ones: Synthesis and Biomedical Applications.吡啶并[2,3-]嘧啶-7(8)-酮:合成与生物医学应用。
Molecules. 2019 Nov 16;24(22):4161. doi: 10.3390/molecules24224161.
4
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.新型酪氨酸激酶抑制剂PD166326在慢性髓性白血病小鼠模型中具有比甲磺酸伊马替尼更强的抗白血病活性。
Blood. 2005 May 15;105(10):3995-4003. doi: 10.1182/blood-2004-09-3534. Epub 2005 Jan 18.
5
A one-pot microwave-assisted synthesis of pyrido[2,3-d]pyrimidines.一锅法微波辅助合成吡啶并[2,3-d]嘧啶。
Mol Divers. 2003;7(2-4):153-9. doi: 10.1023/b:modi.0000006808.10647.f8.
6
A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants.一种新型的abl激酶吡啶并嘧啶抑制剂是Bcr-abl驱动的K562细胞的皮摩尔抑制剂,并且对STI571耐药的Bcr-abl突变体有效。
Clin Cancer Res. 2003 Apr;9(4):1267-73.
7
Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.PD180970对Bcr-Abl激酶活性的抑制作用可阻断Stat5的组成性激活及慢性粒细胞白血病细胞的生长。
Oncogene. 2002 Dec 12;21(57):8804-16. doi: 10.1038/sj.onc.1206028.
8
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.Bcr-Abl和c-kit受体酪氨酸激酶强效抑制剂的特性分析
Cancer Res. 2002 Aug 1;62(15):4244-55.
9
Synthesis and biological activity of 7-oxo substituted analogues of 5-deaza-5,6,7,8-tetrahydrofolic acid (5-DATHF) and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF).
J Med Chem. 2001 Jul 5;44(14):2366-9. doi: 10.1021/jm990411u.
10
The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.吡啶并[2,3-d]嘧啶衍生物PD180970抑制p210Bcr-Abl酪氨酸激酶并诱导K562白血病细胞凋亡。
Cancer Res. 2000 Jun 15;60(12):3127-31.